148 related articles for article (PubMed ID: 19877883)
1. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
[TBL] [Abstract][Full Text] [Related]
2. Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma.
Shih YH; Lin XZ; Yeh CH; Peng CL; Shieh MJ; Lin WJ; Luo TY
Int J Nanomedicine; 2014; 9():4191-201. PubMed ID: 25214783
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ
Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
Huang PW; Tsai SC; Luo TY; Kao CH; Lin WY
Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326
[TBL] [Abstract][Full Text] [Related]
6. A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study.
Lin WY; Luo TY; Tsai SC; Kao CH; Tang IC; Huang PW
Nucl Med Biol; 2013 Apr; 40(3):437-41. PubMed ID: 23352603
[TBL] [Abstract][Full Text] [Related]
7. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma.
Wang SJ; Lin WY; Chen MN; Chi CS; Chen JT; Ho WL; Hsieh BT; Shen LH; Tsai ZT; Ting G; Mirzadeh S; Knapp FF
J Nucl Med; 1998 Oct; 39(10):1752-7. PubMed ID: 9776282
[TBL] [Abstract][Full Text] [Related]
9. Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat.
Garin E; Denizot B; Roux J; Noiret N; Lepareur N; Moreau M; Mesba H; Laurent JF; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
Lab Anim; 2005 Jul; 39(3):314-20. PubMed ID: 16004691
[TBL] [Abstract][Full Text] [Related]
10. Effect of a 188 Re-SSS lipiodol/131I-lipiodol mixture, 188 Re-SSS lipiodol alone or 131I-lipiodol alone on the survival of rats with hepatocellular carcinoma.
Garin E; Rakotonirina H; Lejeune F; Denizot B; Roux J; Noiret N; Mesbah H; Herry JY; Bourguet P; Lejeune JJ
Nucl Med Commun; 2006 Apr; 27(4):363-9. PubMed ID: 16531923
[TBL] [Abstract][Full Text] [Related]
11. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
12. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
Jeong JM; Kim YJ; Lee YS; Ko JI; Son M; Lee DS; Chung JK; Park JH; Lee MC
Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
[TBL] [Abstract][Full Text] [Related]
13. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
Kumar A; Srivastava DN; Bal C
J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
[TBL] [Abstract][Full Text] [Related]
15. Evaluation Efficacy of Rhenium-188-Loaded Micro-particles for Radiotherapy in a Mouse Model of Hepatocellular Carcinoma.
Shih YH; Peng CL; Weng MF; Chiang PF; Luo TY; Lin XZ
Mol Pharm; 2019 Mar; 16(3):1083-1091. PubMed ID: 30638389
[TBL] [Abstract][Full Text] [Related]
16. Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol.
Kumar A; Bal C; Srivastava DN; Thulkar SP; Sharma S; Acharya SK; Duttagupta S
Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):219-23. PubMed ID: 16394805
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients].
Shi L; Zhang Z; Zhuang D; Cheng H; Gao Y; Wu M
Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):814-6. PubMed ID: 12487852
[TBL] [Abstract][Full Text] [Related]
18. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy.
Wang SJ; Lin WY; Chen MN; Hsieh BT; Shen LH; Tsai ZT; Ting G; Knapp FF
Appl Radiat Isot; 1996 Mar; 47(3):267-71. PubMed ID: 8935963
[TBL] [Abstract][Full Text] [Related]
20. Imaging, biodistribution and efficacy evaluation of
Chen LC; Chang YJ; Chen SJ; Lee WC; Chang CH; Lee TW; Shien JH
Int J Radiat Biol; 2017 May; 93(5):477-486. PubMed ID: 28045339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]